Munich, Germany

Albrecht Lindemann

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Albrecht Lindemann: Innovator in Clonogenic Fibroblast Technology

Introduction

Albrecht Lindemann is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the preparation and use of clonogenic fibroblasts. His innovative work has led to advancements that are valuable in various research applications.

Latest Patents

Lindemann holds a patent titled "Methods for preparing and using clonogenic fibroblasts and transfected." This patent showcases his expertise and commitment to enhancing methodologies in cellular biology. He has a total of 1 patent to his name, reflecting his focused contributions to the field.

Career Highlights

Throughout his career, Albrecht Lindemann has demonstrated a strong dedication to research and innovation. His work has been instrumental in developing techniques that improve the understanding and application of fibroblast technology. His efforts have positioned him as a respected figure in the scientific community.

Collaborations

Lindemann has collaborated with esteemed colleagues such as Thomas Boehm and Felicia Rosenthal. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Albrecht Lindemann's contributions to biotechnology, particularly through his patent on clonogenic fibroblasts, highlight his role as an innovator. His collaborations and career achievements further emphasize his impact on the scientific community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…